Genocide North America 2025:
United States of America
COVID-19 Vaccination in the United States of America (to June 2021)
174,234,573 people have received one vaccine dose.
144,919,339 people have received both vaccine doses.
(Infertility, Global Depopulation & Transhumanism)
Section 19 – Moderna
Moderna is an American biotechnology company focused on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA). It is headquartered in Cambridge, Massachusetts. The Moderna technology platform is to insert synthetic mRNA into living cells that would reprogram the cells to develop immune responses, rather than being created externally and injected as with conventional medicines. It is a novel technique abandoned by several large pharmaceutical and biotechnology companies that were unable to overcome the side effects of inserting RNA into cells. As of May 2020, no mRNA drug has been approved for human use.
Moderna conducted mostly unsuccessful trials in traditional high-margin chronic therapeutic areas with AstraZeneca, and in orphan diseases with Alexion Pharmaceuticals. In 2014, Moderna moved to focus on lower-margin vaccines, given that an mRNA vaccine – efficacy issues aside – will always stimulate a level of antibody development in subjects. The strategic change led industry experts, and Moderna employees, to question the financial viability of the company.
In December 2018, Moderna became the largest biotech initial public offering (IPO) in history, raising US$600 million for 8% of its shares, implying an overall valuation of $7.5 billion, and with cumulative losses of $1.5 billion and equity raised of $3.2 billion, since inception. As of May 2020, Moderna was valued at $30 billion, but none of its mRNA molecules had reached large clinical trials, and several had failed due to side-effects. In July 2020, Moderna announced that its mRNA COVID-19 vaccine candidate in Phase 1 clinical testing had led to production of neutralizing antibodies in healthy adults.
Moderna COVID-19 vaccine
The Moderna COVID 19 vaccine, codenamed mRNA-1273, is a COVID-19 vaccine developed by Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA). It is used in people aged 18 years and older to provide protection against infection by the SARS-CoV-2 virus, which causes COVID-19. It is designed to be administered as two 0.5 mL doses given by intramuscular injection at an interval of four weeks apart.
It is an RNA vaccine composed of nucleoside-modified mRNA (modRNA) encoding a spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles.
The Moderna COVID 19 vaccine is authorized for use at some level in 45 countries including the United States, Canada, the European Union, the United Kingdom, Israel, and Singapore.
On 15 March 2021, Moderna’s second COVID 19 vaccine (mRNA-1283) started phase I clinical trials.
HALT ALL COVID-19 VACCINE ROLLOUTS
CDC UPDATED: 1,524 DEAD 31,079 INJURED FOLLOWING EXPERIMENTAL COVID MRNA ‘VACCINES’
Source: Humans Are Free – March 17, 2021
The CDC added more data today into the Vaccine Adverse Event Reporting System (VAERS), a U.S. Government funded database that tracks injuries and deaths caused by vaccines.
Besides the recorded 1,524 deaths, there were 5,806 visits to Emergency Room doctors, 630 permanent disabilities, and 3,477 hospitalizations.
The CDC also updated their Selected Adverse Events Reported after COVID-19 Vaccination page on March 9th this past week, and according to this report, VAERS has received 1,637 reports of death following COVID “vaccinations” – more than 100 deaths than are in the VAERS data dump released today.
The CDC continues to state that not one of these recorded deaths following experimental COVID injections are related to the shots.
“A review of available clinical information including death certificates, autopsy, and medical records revealed no evidence that vaccination contributed to patient deaths.” (Source)
AstraZeneca COVID Vaccine Inoculations Halted In Many Countries Due To Fatal Blood Clots
As we reported yesterday, many countries in Europe (and now also Thailand) have halted the vaccinating of people with the AstraZeneca experimental vaccine after reports of fatal blood clots following the injections.
And while the AstraZeneca COVID shots are not yet authorized for emergency use in the U.S., some have commented that the side effects for the mRNA “vaccines” currently issued EUAs in the U.S. for Pfizer and Moderna have just as many, if not more, adverse side effects, questioning whether any of these new experimental and non-FDA-approved COVID vaccines should be continued.
So we searched today’s CDC data on adverse reactions to the two COVID “vaccines” being used in the U.S. for “pulmonary embolism,” which is an “acute lung disease caused by a dislodged blood clot,” and the reason why the AstraZeneca COVID shot is now being halted in about a dozen countries worldwide after two fatalities and others injured.
This number is obviously far greater than the two deaths reported so far from pulmonary embolism following the AstraZeneca COVID shots being distributed around the world right now.
NO BLACK SUN VACCINE!
A false flag is a covert operation designed to deceive; the deception creates the appearance of a particular party, group, or nation being responsible for some activity, disguising the actual source of responsibility.
Photographic & Promotional Subliminals
Moderna COVID-19 vaccine authorizations
The Moderna COVID-19 vaccine is an mRNA vaccine produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations.